• head_banner_01

ამინომჟავის მინარევები, რომლებიც გამოიყენება ცილის სინთეზირებისთვის

მოკლე აღწერა:

NO

პროდუქტები

CAS არა

1

Fmoc-d-ala-d-ala-oh

NA

2

Fmoc-β-ala-d-ala-oh

NA

3

Fmoc-arg (pbf) -arg (pbf) -oh

NA


პროდუქტის დეტალი

პროდუქტის ტეგები

პროდუქტის დეტალი

NO

პროდუქტები

CAS არა

ძირითადი ხარისხის მაჩვენებელი

სიწმინდე

მაქსიმ.

მინარევა

მთლიანი გამხსნელი ნარჩენები

ტენიანობა

1

Fmoc-β-ala-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

Fmoc-d-ala-d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

Fmoc-β-ala-d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

Fmoc-arg (pbf) -arg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-ala-Arg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

Fmoc-d-arg (pbf) -d-arg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-ala-d-Arg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

Fmoc-homoarg (pbf) -homoarg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-Ala-Homoarg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

Fmoc-asn (trt) -asn (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-ala-asn (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

Fmoc-asp (otbu) -asp (otbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

Fmoc-β-ala-asp (Otbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

FMOC-Cys (TRT) -cys (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-ala-cys (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

FMOC-Cys (ACM) -cys (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-ala-cys (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

Fmoc-gln (trt) -gln (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-ala-gln (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

Fmoc-glu (otbu) -glu (otbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-ala-glu (OTBU) -OH.H2O

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

Fmoc-β-ala-gly-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

Fmoc-his (trt) -his (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-Ala-HIS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

Fmoc-ile-ite-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

Fmoc-β-ala-ile-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

Fmoc-leu-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

Fmoc-β-ala-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

FMOC-D-LEU-D-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

Fmoc-β-ala-d-leu-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-LYS (BOC) -LYS (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-ala-lys (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-LYS (გამოყოფა) -lys (გამოყოფა)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

FMOC-β-ala-lys (გამოყოფა)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

Fmoc-met-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

Fmoc-β-ala-met-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

Fmoc-orn (boc) -orn (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-ala-orn (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

FMOC-PHE-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

Fmoc-β-ala-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

FMOC-D-PHE-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

Fmoc-β-ala-d-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

Fmoc-pro-pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

Fmoc-β-ala-pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

Fmoc-ser (tbu) -ser (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-ala-ser (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

Fmoc-ser (trt) -ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β-Ala-SER (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

FMOC-THR (TBU) -THR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-ALA-THR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

FMOC-β-Ala-Trp (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-Ala-D-Trp (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

Fmoc-tyr (tbu) -tyr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-ala-tyr (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

FMOC-D-Tyr (ET) -D-Tyr (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-Ala-D-Tyr (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

Fmoc-tyr (me) -tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

Fmoc-β-ala-tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

FMOC-Val-Val-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

Fmoc-β-ala-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D-CIT-D-CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

Fmoc-β-ala-d-cit-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

Fmoc-β-ala-dab-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

Fmoc- (3- (2-ნაფტილ) -D-ალა) 2-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-ALA-3- (2-ნაფტილ) -D-ალა-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

Fmoc- (3- (3- პირიდინილ) -D-ალა) 2-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-ALA-3- (3-პირიდინილ) -D-ალა-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4-ქლორო- D-Phe) 2-ოჰ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-β-ALA-4-Chloro-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4APH (TBUCBM)) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-ALA-D-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

Fmoc-aph (l-hor) -aph (l-hor) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-ala-aph (L-Hor) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMOC-Lys (IPR, BOC) -Lys (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-Ala-Lys (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

Fmoc-β-ala-aeea-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

FMOC-AIB-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

Fmoc-β-ala-aib-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

Fmoc-arg-oh

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-arg (pbf) -oh

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

Fmoc-d-arg-oh

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

Hd-arg (pbf) -oh

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

Fmoc-homoarg-oh.hcl

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-homoarg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

Fmoc-d-homoarg-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

Hd-homoarg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

Fmoc-asn-oh

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-asn (trt) -oh

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

Fmoc-asp-oh

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-asp (Otbu) -oh

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

Fmoc-cys-oh

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-cys (trt) -oh

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-cys (acm) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

Fmoc-gln-ოჰ

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-gln (trt) -oh

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

FMOC-GLU-OH

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-glu (Otbu) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

Fmoc-his-oh

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-–-(trt) -oh

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-his-oh

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

Fmoc-lys-oh

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-lys (BOC) -OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-lys (გამოყოფა) -OH

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

Fmoc-orn-oh.hcl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-orn (boc) -oh

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

FMOC-SER-OH

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-ser (tbu) -oh

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

Fmoc-thr-oh.h2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-Thr (TBU) -OH

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

FMOC-TRP-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-trp (boc) -oh

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

FMOC-D-TRP-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -OH

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

Fmoc-tyr-oh

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-tyr (tbu) -oh

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

FMOC-D-Tyr-OH

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-Tyr (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-tyr (me) -oh.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4APH (CBM) -OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

Fmoc-lys (ipr) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-lys (ipr, boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

გარშემო

კომპენსაცია

Gentolex უზრუნველყოფს შესანიშნავი ხარისხის პროდუქტებს, თუ ნებისმიერი პროდუქტის ხარისხი იზრდება კლიენტის მიერ საჭირო ვადებში, საკმარისი მტკიცებულებებით, ჩვენ მოგაწვდით აუცილებელ ანალიზს და შეფასებას კომპენსაციების პროცედურების შესაქმნელად.

წარმოება

ფარმაცევტული პროდუქტების შესაძლებლობებმა მიაღწია ტონას კლასს, ქიმიური პროდუქტების შესაძლებლობები 100 ტონს+ კლასს აღწევს, შესაძლებლობები კარგად არის აღჭურვილი, რომ მთელ მსოფლიოში კლიენტებს ემსახურებიან.

კვლევა და განვითარება

ყოველწლიურად, R&D გუნდის მიერ არის შექმნილი გეგმა, რომ შეიმუშაოს სხვადასხვა ახალი პროდუქტი, როდესაც მიზნები დადგენილია, გუნდში ყველა წევრს მოუწევს გააგრძელოს KPI პასუხისმგებლობა და სტიმულირების პოლიტიკა.


  • წინა:
  • შემდეგი:

  • დაწერე შენი შეტყობინება აქ და გამოგვიგზავნე